// App-Quantinova.ai

PB1922 : EFFECTIVENESS OF AZACITIDINE IN FRONTLINE HIGHER-RISK MYELODYSPLASTIC SYNDROME (HR MDS): A RETROSPECTIVE COHORT STUDY OF 382 PATIENTS

Researchers

Presenter

  • Nishanthan Rajakumaraswamy

Principal Investigators

  • Mitul Gandhi

  • Andrew H Wei

  • David A Sallman

  • Naval G Daver

  • Shuyuan Mo

  • Shahed Iqbal

  • Manli Chen

  • Yunfei Wang

  • Paresh Vyas

Medical Centers

  • Ontada,The Woodlands,Vereinigte Staaten

  • Department of Clinical Haematology,Peter MacCallum Cancer Centre and The Royal Melbourne Hospital,Melbourne,Australie

  • Gilead Sciences, Inc.,Foster City,Stati Uniti

  • Department of Clinical Haematology,Peter MacCallum Cancer Centre and The Royal Melbourne Hospital,Melbourne,Australie

  • Ontada,The Woodlands,Stati Uniti

  • Department of Medicine,University of Oxford Radcliffe,Oxford,Reino Unido

  • Haematology at Peter MacCallum Cancer Centre and The Royal Melbourne Hospital,Melbourne, VIC,Australie

  • Department of Leukemia,University of Texas MD Anderson Cancer Center,Houston,Vereinigte Staaten

  • Department of Medicine,University of Oxford Radcliffe,Oxford,Reino Unido

  • Fairfax Office,Virginia Cancer Specialists,Fairfax,États-unis

  • Virginia Cancer Specialists,Fairfax,Verenigde Staten

  • Moffitt Cancer Center,Tampa, FL,Stati Uniti

  • Department of Leukemia,University of Texas MD Anderson Cancer Center,Houston,Vereinigte Staaten

  • Moffitt Cancer Center,Tampa,Verenigde Staten

  • Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, Houston, TX

  • Gilead Sciences, Inc.,Foster City,Vereinigte Staaten

  • Virginia Cancer Specialists, Fairfax, VA, United States

  • Moffitt Cancer Center, Tampa, FL

  • Department of Clinical Haematology,Peter MacCallum Cancer Centre and The Royal Melbourne Hospital,Melbourne,Australie

  • Department of Medicine,University of Oxford Radcliffe,Oxford,Reino Unido

  • Department of Medicine,University of Oxford Radcliffe,Oxford,Reino Unido

  • Ontada,The Woodlands,USA

  • Gilead Sciences, Inc.,Foster City,Vereinigte Staaten

  • Department of Clinical Haematology,Peter MacCallum Cancer Centre and The Royal Melbourne Hospital,Melbourne,Australie

  • Ontada,The Woodlands,Estados Unidos

  • Ontada,The Woodlands,Vereinigte Staaten

  • Department of Medicine,University of Oxford Radcliffe,Oxford,Reino Unido

  • Gilead Sciences, Inc.,Foster City,Stati Uniti

  • Department of Clinical Haematology,Peter MacCallum Cancer Centre and The Royal Melbourne Hospital,Melbourne,Australie

  • Moffitt Cancer Center,Tampa,Verenigde Staten

  • Department of Leukemia, The University of Texas MD Anderson Cancer Center,...

  • Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, Houston, TX

  • Department of Medicine,University of Oxford Radcliffe,Oxford,Reino Unido

  • Gilead Sciences, Inc., Foster City, CA, United States.

  • Fairfax Office,Virginia Cancer Specialists,Fairfax,États-unis

  • Ontada,The Woodlands,United States

  • Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States

  • Virginia Cancer Specialists, Fairfax, VA

  • Moffitt Cancer Center,Tampa, FL,Stati Uniti

  • Moffitt Cancer Center, Tampa, Florida, United States

  • Department of Leukemia,University of Texas MD Anderson Cancer Center,Houston,Vereinigte Staaten

  • Ontada,The Woodlands,États-unis

  • Gilead Sciences, Inc., Foster City, CA

  • Department of Medicine,University of Oxford Radcliffe,Oxford,Reino Unido

  • Department of Medicine,University of Oxford Radcliffe,Oxford,Соединённое Королевство

  • Gilead Sciences, Inc.,Foster City,Stati Uniti

  • Mofitt Cancer Center,Tampa, FL,Estados Unidos

Locations

  • United States

  • Australia

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Alpha-thalassemia myelodysplasia syndrome

Biomarkers

  • Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Epsilon

Drug/Treatment

  • Vidaza

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved